NCT02012413

Brief Summary

PST (pulsed signal therapy) is a unique form of pulsed electromagnetic field therapy (PEMF) for stimulating healing of damaged structures such as cartilage, bones and soft tissues. The physical effect of the pulsed electromagnetic field (PEMF) has been focus of research in various studies, with cartilage being the most studied, and which has demonstrated an increase in the synthesis of proteoglican and collagen in vitro. This is an randomized, controlled and double blind clinical trial. The main objective is to evaluate clinical improvement regarding anterior knee pain after PST intervention in patients with patellar condropathy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
41

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2012

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2013

Completed
4 months until next milestone

First Posted

Study publicly available on registry

December 16, 2013

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2015

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
Last Updated

April 25, 2017

Status Verified

April 1, 2017

Enrollment Period

2.3 years

First QC Date

August 8, 2013

Last Update Submit

April 23, 2017

Conditions

Keywords

kneechondromalaciapatellapulsed signal therapyPST

Outcome Measures

Primary Outcomes (1)

  • Clinical improvement - Kujala score

    A functional score (Kujala) will be performed before, at 3 months, at 6 months and at one year after PST intervention and placebo.

    12 months

Study Arms (2)

PST group

ACTIVE COMPARATOR

roughly 20 patients will be treated with PST protocol, outcomes will be Kujala score improvement at 3, 6 and 12 months.

Device: PST - Pulsed Signal Therapy

Control group

PLACEBO COMPARATOR

roughly 20 patients will be submitted to a placebo PST protocol, outcomes will be Kujala score improvement at 3, 6 and 12 months.

Device: Placebo - Sham PST

Interventions

PST application is a painless over-the-skin eletromagnetic field application. 9 sessions of application of electromagnetic therapy - PST - during 60 minutes

Also known as: PST, PEMF, Pulsed Eletromagnetic Field
PST group

Placebo PST will be performed by applying the same device over the patient knee. The machine is not applying the PST but it appears to be on. In this way, patients are blinded to the intervation. 9 sessions of application of Sham PST - during 60 minutes

Also known as: Placebo
Control group

Eligibility Criteria

Age20 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • patellofemoral pain syndrome without tibiofemoral and trochlear chondral degeneration according to magnetic resonance imaging (MRI);
  • presence of patellar chondropathy confirmed by MRI;
  • not having started using direct action drugs on the cartilage in the last 6 months;
  • absence of prior surgery on the studied knee;
  • absence of invasive procedures, such as knee infiltration, in the previous 12 months;
  • absence of disease in the contralateral limb that would cause an excessive burden on the studied limb; and
  • absence of contraindications to performing PST, including a pacemaker, cancer, infectious disease activity, severe heart failure, arrhythmias, angina, epilepsy and pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital das Clínicas - Universty of São Paulo

São Paulo, 05403-010, Brazil

Location

MeSH Terms

Conditions

Chondromalacia PatellaeCartilage DiseasesPatella Fracture

Condition Hierarchy (Ancestors)

Musculoskeletal DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesKnee FracturesFractures, BoneWounds and Injuries

Study Officials

  • Adriana Lucia P Silva, B.Sc., M.Sc.

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR
  • Riccardo G Gobbi, M.D.

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR
  • Gilberto L Camanho, M.D., Ph.D

    University of Sao Paulo

    STUDY CHAIR
  • Marco K Demange, M.D., Ph.D

    University of Sao Paulo

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 8, 2013

First Posted

December 16, 2013

Study Start

November 1, 2012

Primary Completion

March 1, 2015

Study Completion

December 1, 2015

Last Updated

April 25, 2017

Record last verified: 2017-04

Locations